Financial figures

Overview of DSM's latest financial key figures

Overview as at Q1 2019

Presented below are DSM's net sales from continuing operations, adjusted net earnings per ordinary share, balance sheet, income statement and finally, cash flow statement, as at Q1 2019.

Net sales (continuing operations) in € million

Year Q1 Q2 Q3 Q4 Total
2019 2,292 2,276      
2018 2,435 2,359 2,265 2,208 9,267
2017 2,159 2,161 2,136 2,176 8,632
2016 1,913 1,994 1,998 2,015 7,920
2015 1,886 1,754 2,102 1,926 7,722
2014 2,298 2,288 2,323 2,175 9,181
2013 2,376 2,468 2,397 2,377 9,618
2012 2,290 2,268 2,304 2,269 9,131
2011 2,234 2,265 2,322 2,227 9,048
2010 1,933 2,120 2,041 2,082 8,176
2009 1,578 1,664 1,725 1,758 6,725
2008 2,303 2,406 2,336 2,034 9,079

Adjusted net earnings per ordinary share (continuing operations)

Year Q1 Q2 Q3 Q4 Total
2019 1.12 1.20      
2018 1.91 1.73 1.18 1.02 5.84
2017 0.92 0.98 0.91 1.11 3.92
2016 0.60 0.76 0.81 0.73 2.90
2015 0.39 0.63 0.59 0.53 2.14
2014 0.57 0.64 0.69 0.52 2.42
2013 0.70 0.79 0.76 0.58 2.84
2012 0.87 0.67 0.61 0.43 2.58
2011 0.91 0.97 0.94 0.71 3.53
2010 0.70 0.92 0.76 0.63 2.89
2009 0.05 0.22 0.53 0.56 1.44
2008 0.81 1.00 0.97 0.25 3.04

Balance sheet

Assets in € million 30 Jun 2019 Year-end 2018
Intangible Assets 3,233 3,090
Property, Plant & Equipment 3,764 3,511
Deferred Tax Assets 215 248
Share in Associates & Joint Ventures 152 205
Financial derivatives 12 14
Other Financial Assets 259 263
Non-Current Assets 7,635 7,331
Inventories 2,071 1,993
Trade Receivables 1,742 1,575
Income tax receivables 78 83
Other Current Receivables 56 80
Financial Derivatives 33 21
Current Investments 1,149 1,277
Cash & Cash Equivalents 1,137 1,281
Current Assets 6,266 6,310
Total Assets 13,901 13,641
Equity & Liabilities in € million 30 Jun 2019 Year-end 2018
Shareholders' Equity 7,786 7,782
Non-controlling interest 54 33
Equity 7,840 7,815
Deferred Tax Liabilities 248 254
Employee Benefits Liabilities 458 413
Provisions 108 116
Borrowings 2,432 2,272
Financial derivatives 4 3
Other Non-current Liabilities 116 197
Non-current liabilities 3,366 3,255
Employee Benefits 46 46
Provisions 41 37
Borrowings 438 380
Financial Derivatives 46 51
Trade Payables 1,452 1,430
Income tax payable 88 100
Other Current Liabilities 584 527
Current Liabilities 2,695 2,571
Total Equity and Liabilities 13,901 13,641
Net debt 589 113
Equity/Total Assets 56% 57%

Income statement

Condensed consolidated statement of income H1 2019

In € million H1 2019 H1 2018
Sales 2,276 2,359
EBITDA 407 503
Operating profit (EBIT) 247 389
Financial income and expense -28 -25
Profit before income tax expense 219 364
Income tax expense -36 -64
Share of the profit of associates /joint control entities 22 2
Net profit 205 302
Of which:    
Profit attributable to non-controlling interests -1 -1
Net profit attributable to equity holders of DSM 204 301
Dividend on cumulative preference shares -2 -2
Net profit available to holders of ordinary shares 202 299
Depreciation and amortization 160 114

Reconciliation to Alternative Performance Measures H1 2019

In € million H1 2019 H1 2018
EBITDA 407 503
Acquisitions/divestments 1 -4
Restructuring 30 10
Other 0 -1
Sub-total APM adjustments to EBITDA 31 5
Adjusted EBITDA 438 508
Operating profit (EBIT) 247 389
APM adjustments to EBITDA 31 5
Impairments of PPE and Intangible assets 11 0
Sub-total APM adjustments to operating profit (EBIT) 42 5
Adjusted operating profit (EBIT) 289 394
Net profit 205 302
APM adjustments to operating profit (EBIT) 42 5
APM adjustments to financial income and expense 0 0
Income tax related to APM adjustments -11 -2
APM adjustments to share of the profit of associates/ joint control entities -21 1
Sub-total APM adjustments to net profit  10 4
Adjusted net profit 215 306
     
Net profit available to holders of ordinary shares 202 299
APM adjustments to net profit 10 4
Adjusted net profit available to holders of ordinary shares 212 303
Average number of ordinary shares (million) 176.5 175.2
Earnings per share (EPS) (in €):    
Net earnings per share 1.14 1.70
Adjusted net earnings per share 1.20 1.73

Cash flow statement

Assets in € million H1 2019 H1 2018
Cash, Cash Equivalents and Current Investments
(at beginning of period)		 2,558 1,853
Current Investments (at beginning of period) 1,277 954
Cash & Cash Equivalents (at beginning of period) 1,281 899
     
Operating Activities    
EBITDA 823 1,029
Change in Working  Capital -239 -504
Income Tax -51 -43
Other -26 21
Cash provided by Operating Activities (Operating cash flow) 507 503
     
Investing Activities    
Capital Expenditures -269 -301
Payment of lease liabilities* 0 -18
Payments regarding drawing rights -4 -17
Acquisitions -207 -2
Disposal of Subsidiaries, Businesses & Associates 2 30
Disposal of Other Non-current Assets 3 1
Change in Fixed-term Deposits 128 -52
Interest Received 5 9
Dividend and capital (re)payments -12 -21
Other 23 7
Cash used in Investing Activities -331 -364
Dividend -158 -139
Interest Paid -31 -25
Repurchase of shares -249 -137
Proceeds from re-issued treasury shares 136 58
Change in Commercial Paper    
Proceeds from / repayments of corporate bonds    
Payment of lease liabilities -26 0
Other Cash from/ used in Financing Activities 11 33
Cash from /used in Financing Activities -317 -210
Exchange Differences -3 -15
Cash and Cash Equivalents (end of period) 1,137 813
Current Investment (end of period) 1,149 1,006
Cash and Cash Equivalents & Current Investments (end of period) 2,286 1,819

Read more

  • Share center

    DSM's ordinary shares, share performance, share listings, share structure, cumulative preference shares and shareholder base.

This site uses cookies to store information on your computer.

Learn more